Natural history of adult-onset Ménétrier's disease: Report of a case with 9-year follow-up

Xiong,Li‑Shou; Gong,Ying‑Ying

doi:10.3892/etm.2016.3181

Natural history of adult-onset Ménétrier's disease: Report of a case with 9-year follow-up

Authors:
- Li‑Shou Xiong
- Ying‑Ying Gong
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Geriatrics, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: March 23, 2016 https://doi.org/10.3892/etm.2016.3181
Pages: 2462-2466

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ménétrier's disease (MD) is a rare disease characterized by markedly hypertrophied gastric mucosal folds typically associated with hypoalbuminemia and anemia. However, the natural history of MD in adults remains unclear and is rarely reported in the literature. The current study presents a case of MD with a 9‑year follow‑up. A 56‑year‑old man was diagnosed with MD in 2005. The patient was followed up and underwent surveillance endoscopy once or twice each year. In the present case, the anemia and hypoproteinemia were eliminated following red blood cell transfusion and intravenous iron therapies. The symptoms were relieved after 4 years. Treatment with octreotide had little effect on the gastric mucosa, while antimicrobial combination therapy provided no benefit in the present H. pylori‑negative case of MD. In addition, despite abnormalities of the gastric mucosa in the patient persisting after 9 years of follow-up with no evidence of malignancy, malignant transformation in MD should not be overlooked, and regular monitoring of the gastric mucosa via endoscopy is necessary.

View Figures

View References

1	Coffey RJ Jr and Tanksley J: Pierre Ménétrier's and his disease. Trans Am Clin Climatol Assoc. 123:126–134. 2012.PubMed/NCBI
2	Eisenstat DD, Griffiths AM, Cutz E, Petric M and Drumm B: Acute cytomegalovirus infection in a child with Ménétrier's disease. Gastroenterology. 109:592–595. 1995. View Article : Google Scholar : PubMed/NCBI
3	Scharschmidt BF: The natural history of hypertrophic gastrophy (Menetrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med. 63:644–652. 1977. View Article : Google Scholar : PubMed/NCBI
4	Badov D, Lambert JR, Finlay M and Balazs ND: Helicobacter pylori as a pathogenic factor in Menetrier's disease. Am J Gastroenterol. 93:1976–1979. 1998. View Article : Google Scholar : PubMed/NCBI
5	Jun DW, Kim DH, Kim SH, Song MH, Lee HH, Kim SH, Jo YJ and Park YS: Menetrier's disease associated with herpes infection: Response to treatment with acyclovir. Gastrointest Endosc. 65:1092–1095. 2007. View Article : Google Scholar : PubMed/NCBI
6	Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, Ahlquist DA, Pittelkow MR, Lee DC, Sandgren EP, et al: Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier's disease: Supportive evidence form humans and transgenic mice. Gastroenterology. 103:1950–1963. 1992.PubMed/NCBI
7	Yeaton P and Frierson HF Jr: Octreotide reduces enteral protein losses in Ménétrier's disease. Am J Gastroenterol. 88:95–98. 1993.PubMed/NCBI
8	Burdick JS, Chung E, Tanner G, Sun M, Paciga JE, Cheng JQ, Washington K, Goldenring JR and Coffey RJ: Treatment of Ménétrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 343:1697–1701. 2000. View Article : Google Scholar : PubMed/NCBI
9	Di Vita G, Patti R, Aragona F, Leo P and Montalto G: Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy. Dig Dis. 19:179–183. 2001. View Article : Google Scholar : PubMed/NCBI
10	Mosnier JF, Flejou JF, Amouyal G, Gayet B, Molas G, Henin D and Potet F: Hypertrophic gastropathy with gastric adenocarcinoma: Menetrier's disease and lymphocytic gastritis? Gut. 32:1565–1567. 1991. View Article : Google Scholar : PubMed/NCBI
11	Rothenberg M, Pai R and Stuart K: Successful use of octreotide to treat Ménétrier's disease: A rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia. Dig Dis Sci. 54:1403–1407. 2009. View Article : Google Scholar : PubMed/NCBI
12	Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD, Piessevaux H, Washington MK and Coffey RJ: Distinguishing Ménétrier's disease from its mimics. Gut. 59:1617–1624. 2010. View Article : Google Scholar : PubMed/NCBI
13	Kaneko T, Akamatsu T, Gotoh A, Shimodaira K, Shimizu T, Kiyosawa K, Katsuyama T and Momose A: Remission of Menetrier's disease after a prolonged period with therapeutic eradication of Helicobacter pylori. Am J Gastroenterol. 94:272–273. 1999. View Article : Google Scholar : PubMed/NCBI
14	Singh AK, Cumaraswamy RC and Corrin B: Diffuse hypertrophy of gastric mucosa (Menetrier's disease) and iron-deficiency anaemia. Gut. 10:735–737. 1969. View Article : Google Scholar : PubMed/NCBI
15	Yoshimura M, Hirai M, Tanaka N, Kasahara Y and Hosokawa O: Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Menetrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. Intern Med. 42:971–977. 2003. View Article : Google Scholar : PubMed/NCBI
16	Bayerdorffer E, Ritter MM, Hatz R, Brooks W and Stolte M: Menetrier's disease and Helicobacter pylori. N Engl J Med. 329:601993. View Article : Google Scholar : PubMed/NCBI
17	Kawasaki M, Hizawa K, Aoyagi K, Nakamura S and Fujishima M: Ménétrier's disease associated with Helicobacter pylori infection: Resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. Am J Gastroenterol. 92:1909–1912. 1997.PubMed/NCBI
18	Raderer M, Oberhuber G, Templ E, Wagner L, Pötzi R, Wrba F, Hejna M and Base W: Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment. Digestion. 60:358–362. 1999. View Article : Google Scholar : PubMed/NCBI
19	Pinski J, Halmos G and Schally AV: Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett. 71:189–196. 1993. View Article : Google Scholar : PubMed/NCBI
20	Watt HL, Kharmate GD and Kumar U: Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: Agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell Signal. 21:428–439. 2009. View Article : Google Scholar : PubMed/NCBI
21	Vandenborre KM, Ghillebert GL, Rutgeerts LJ, Geboes KR, Rutgeerts PJ, Verbanck JJ and Tanghe WR: Hypertrophic lymphocytic gastritis with a gastric carcinoma. Eur J Gastroenterol Hepatol. 10:797–801. 1998. View Article : Google Scholar : PubMed/NCBI
22	Choi SB, Park SS, Oh SY, Kim JH, Kim WB, Lee JH, Choi JW, Kim SJ, Kim CS and Mok YJ: Primary squamous cell carcinoma of the stomach that developed with Menetrier's disease. Dig Dis Sci. 52:1722–1724. 2007. View Article : Google Scholar : PubMed/NCBI
23	Wood MG, Bates C, Brown RC and Losowsky MS: Intramucosal carcinoma of the gastric antrum complicating Menetrier's disease. J Clin Pathol. 36:1071–1075. 1983. View Article : Google Scholar : PubMed/NCBI
24	Ramia JM, Sancho E, Lozano O, Santos JM and Domínguez F: Ménétrier's disease and gastric cancer. Cir Esp. 81:153–154. 2007.(In Spanish). PubMed/NCBI